A Human Proteome Detection and Quantitation Project*

The lack of sensitive, specific, multiplexable assays for most human proteins is the major technical barrier impeding development of candidate biomarkers into clinically useful tests. Recent progress in mass spectrometry-based assays for proteotypic peptides, particularly those with specific affinity peptide enrichment, offers a systematic and economical path to comprehensive quantitative coverage of the human proteome. A complete suite of assays, e.g. two peptides from the protein product of each of the ∼20,500 human genes (here termed the human Proteome Detection and Quantitation project), would enable rapid and systematic verification of candidate biomarkers and lay a quantitative foundation for subsequent efforts to define the larger universe of splice variants, post-translational modifications, protein-protein interactions, and tissue localization.

[1]  Robertson Craig,et al.  Open source system for analyzing, validating, and storing protein identification data. , 2004, Journal of proteome research.

[2]  L L Needham,et al.  Isotope dilution--mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. , 1996, Clinical chemistry.

[3]  Henry H. N. Lam,et al.  PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows , 2008, EMBO reports.

[4]  Leigh Anderson,et al.  Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins* , 2006, Molecular & Cellular Proteomics.

[5]  C. Perou,et al.  Development of an immuno tandem mass spectrometry (iMALDI) assay for EGFR diagnosis , 2007, Proteomics. Clinical applications.

[6]  James A. Cuff,et al.  Distinguishing protein-coding and noncoding genes in the human genome , 2007, Proceedings of the National Academy of Sciences.

[7]  S. Carr,et al.  Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution*S , 2007, Molecular & Cellular Proteomics.

[8]  T. Fitzgerald,et al.  Quantitative analysis of thymosin alpha1 in human serum by LC-MS/MS. , 2000, AAPS PharmSciTech.

[9]  B. Yin,et al.  Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody (VK‐8): identification as a mucin‐type molecule , 1997, International journal of cancer.

[10]  V. Armstrong,et al.  Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. , 2002, Clinical chemistry.

[11]  S. Gygi,et al.  Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Dubose,et al.  A strategic view on the use of pharmacodynamic biomarkers in early clinical drug development. , 2006, IDrugs : the investigational drugs journal.

[13]  Andrew N Hoofnagle,et al.  Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. , 2008, Clinical chemistry.

[14]  Ruth Etzioni,et al.  Early detection: The case for early detection , 2003, Nature Reviews Cancer.

[15]  Robertson Craig,et al.  The use of proteotypic peptide libraries for protein identification. , 2005, Rapid communications in mass spectrometry : RCM.

[16]  R. Aebersold,et al.  Scoring proteomes with proteotypic peptide probes , 2005, Nature Reviews Molecular Cell Biology.

[17]  N. Anderson,et al.  The Human Plasma Proteome: History, Character, and Diagnostic Prospects , 2003, Molecular & Cellular Proteomics.

[18]  Darryl B. Hardie,et al.  Mass spectrometric quantitation of peptides and proteins using Stable Isotope Standards and Capture by Anti-Peptide Antibodies (SISCAPA). , 2004, Journal of proteome research.

[19]  T. Fitzgerald,et al.  Quantitative analysis of thymosin α1 in human serum by LC-MS/MS , 2000, AAPS PharmSciTech.

[20]  T. Pearson,et al.  Anti-peptide antibody screening: selection of high affinity monoclonal reagents by a refined surface plasmon resonance technique. , 2009, Journal of immunological methods.

[21]  N G Anderson,et al.  The Human Protein Index. , 1981, Clinical chemistry.

[22]  Belinda Bullard,et al.  High throughput production of mouse monoclonal antibodies using antigen microarrays , 2005, Proteomics.

[23]  R. Kostiainen,et al.  Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies. , 2003, Journal of mass spectrometry : JMS.

[24]  D. Desiderio,et al.  High-performance liquid chromatographic and field desorption mass spectrometric measurement of picomole amounts of endogenous neuropeptides in biologic tissue. , 1981, Journal of chromatography.